Clinical trialNCT03984305TerminatedInterventional

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG

SponsorGlobal Kinetics CorporationEnrollment41Parkinson Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main objective of this study is to evaluate whether people whose PD symptoms are uncontrolled who are managed with the aid of objective measurement and use of target ranges have improved PD symptoms and outcomes as compared to individuals treated using only standard of care (medical history, neurological examination).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Raja Mehanna, MD
The University of Texas Health Science Center, Houston
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Washington Regional Medical Center
Fayetteville, Arkansas, United States
University of Arkansas Medical Center
Little Rock, Arkansas, United States
Parkinson'S Disease and Movement Disorders Center of Silicon Valley
Menlo Park, California, United States
Parkinson'S Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, United States
University of Florida
Gainesville, Florida, United States
University of South Florida
Tampa, Florida, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Kaiser Mid-Atlantic Permanente Center
Rockville, Maryland, United States
Neurology Center of New England
Foxborough, Massachusetts, United States
Michigan State University
East Lansing, Michigan, United States
University of Nebraska
Omaha, Nebraska, United States
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada, United States
Parkinson'S Disease and Movement Disorders Center of Long Island
Commack, New York, United States
Weill Cornell
New York, New York, United States
University of Texas
Houston, Texas, United States
Marshall University
Huntington, West Virginia, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Oct 2019
Primary completion: 16 Oct 2020
Completion: 16 Oct 2020
Last update posted: 8 Feb 2022
Registered enrollment: 41
Registry id: NCT03984305

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.